Total operating earnings
Breakdown
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Pharmaceutical and Specialty Solutions | $484.00M | $530.00M | $531.00M | $662.00M | $535.00M | $667.00M | $687.00M | $784.00M |
| Other Segments | $110.00M | $104.00M | $118.00M | $134.00M | $160.00M | $166.00M | $179.00M | $179.00M |
| Cost of product sold | $49.00M | $8.00M | $18.00M | $39.00M | $70.00M | $46.00M | $37.00M | $25.00M |
| Total | $406.00M | $568.00M | $549.00M | $730.00M | $428.00M | $668.00M | $707.00M | $509.00M |
Segments
Pharmaceutical and Specialty SolutionsView metric
Cost of product soldView metric
Other SegmentsView metric